Cravath’s London Office Moves to 100 Cheapside
Widely recognized as a leader in intellectual property litigation, Cravath has handled challenging intellectual property disputes for generations, often involving our clients’ most valuable and complex technologies and products. Today, our expertise covers the entire innovation marketplace, spanning the pharmaceutical, biotechnology, consumer products, technology and industrial sectors, among others. In a quickly advancing intellectual property landscape, Cravath’s litigators devise effective solutions to complex problems by combining “incredible intellectual horsepower, diligence, exceptional teamwork and dedication.” (IAM Patent 1000)
Clients ranging from innovative start-ups to major global companies regularly call on Cravath to lead intellectual property matters of the highest complexity and business significance. Our attorneys bring to the table not only “incredible IP and policy knowledge,” but also outside‑the‑box thinking, courtroom credibility and masterful trial advocacy in all aspects of high‑stakes intellectual property litigation. (Chambers USA) Cravath’s litigators are adept at handling a wide variety of disputes involving patents, copyrights, trade secrets and trademarks, as well as the commercial litigation that frequently arises from these matters, such as antitrust and breach of license claims. We bring to each case a trial lawyer’s courtroom perspective and deep trial experience, which distinguishes us from many firms that may be intellectual property specialists but do not try cases on a regular basis.
Our team also supervises and coordinates intellectual property disputes that span the globe and regularly advises on national and worldwide intellectual property strategy, earning praise for our “ability to orchestrate litigation pretty much anywhere in the world.” (Chambers USA)
Cravath has handled patent litigation since the nineteenth century, and we continue to be at the forefront of the field, tackling today’s most “brain‑bendingly complex must‑win company suits.” (IAM Patent 1000) We regularly work with cutting‑edge pharmaceutical, medical device and technology companies in highly contested patent litigation that goes to the heart of our clients’ businesses. Notably, we have significant experience taking patent cases to trial, particularly in the biotechnology area, and litigated one of the first cases to proceed under the Biologics Price Competition and Innovation Act.
Cravath has received first‑tier rankings in patent litigation in the Best Lawyers survey of the best law firms in the United States, has been recognized for patent litigation by LMG Life Sciences and Intellectual Asset Management, and was previously named among Patexia Insight’s Top Inter Partes Review Firms. The Legal 500 US has credited the Firm’s “superb trial lawyers with a long track record in dealing with complex patent litigation,” and noted that “when stakes are high in a patent case, Cravath is the team to engage.”
Cravath has extensive experience representing content owners, content distributors and others in prosecuting and defending copyright infringement claims, including in landmark actions that shape the law’s development. We have established important precedent impacting copyright-heavy industries, such as film, television, music and digital media, and recently won a U.S. Supreme Court decision holding that the Copyright Act permits damages recovery for any timely filed infringement claim, regardless of when the infringement occurred. A victory for all creators of copyrightable works, the ruling resolved a critical issue that had divided the federal appellate courts. In addition to our active litigation practice, we routinely advise clients on a variety of copyright issues, including those related to the Digital Millennium Copyright Act, renewal rights issues, digital media and other new and emerging technologies. We also regularly advise on potential copyright and other contractual issues in programming, recording and publishing contracts.
The breadth and depth of Cravath’s litigation expertise is invaluable in prosecuting (or defending) claims involving trade secrets. The Legal 500 US noted Cravath’s particular strength “in bringing complex, high‑value trade secret disputes to trial on behalf of plaintiffs in the insurance, finance and technology sectors, and defending them against claims,” as well as the Firm’s “considerable track record advising various parties on strategies to avoid trade secrets disputes.” Cravath also possesses substantial experience in investigating potential or suspected misuse or misappropriation of trade secrets. The Firm frequently advises clients on methods of protecting proprietary information, including confidentiality and noncompetition agreements with employees, and conducts due diligence with respect to unpatented proprietary information in connection with mergers and acquisitions and other transactions.
Cravath advises and represents clients on a wide range of issues arising under the trademark laws. We have defended clients against allegations of trademark infringement and trademark dilution, as well as against related claims of unfair competition and breach of trademark licensing agreements. We also have brought claims and counterclaims to enforce important trademark rights.
Named New York Law Journal’s “Litigation Department of the Year” three times in the past six years, most recently in 2024, and a Law360 “Firm of the Year” in 2024 and 2021, Cravath’s IP team has been ranked as a leading or top‑tier firm in the intellectual property space by Benchmark Litigation, Chambers USA, Chambers Global, IAM Patent 1000, LMG Life Sciences, The Legal 500 US and Best Lawyers Best Law Firms. In addition, we have earned repeated praise from clients and the market, including:
Clients ranging from innovative start-ups to major global companies regularly call on Cravath to lead intellectual property matters of the highest complexity and business significance. Our attorneys bring to the table not only “incredible IP and policy knowledge,” but also outside‑the‑box thinking, courtroom credibility and masterful trial advocacy in all aspects of high‑stakes intellectual property litigation. (Chambers USA) Cravath’s litigators are adept at handling a wide variety of disputes involving patents, copyrights, trade secrets and trademarks, as well as the commercial litigation that frequently arises from these matters, such as antitrust and breach of license claims. We bring to each case a trial lawyer’s courtroom perspective and deep trial experience, which distinguishes us from many firms that may be intellectual property specialists but do not try cases on a regular basis.
Our team also supervises and coordinates intellectual property disputes that span the globe and regularly advises on national and worldwide intellectual property strategy, earning praise for our “ability to orchestrate litigation pretty much anywhere in the world.” (Chambers USA)
Cravath has handled patent litigation since the nineteenth century, and we continue to be at the forefront of the field, tackling today’s most “brain‑bendingly complex must‑win company suits.” (IAM Patent 1000) We regularly work with cutting‑edge pharmaceutical, medical device and technology companies in highly contested patent litigation that goes to the heart of our clients’ businesses. Notably, we have significant experience taking patent cases to trial, particularly in the biotechnology area, and litigated one of the first cases to proceed under the Biologics Price Competition and Innovation Act.
Cravath has received first‑tier rankings in patent litigation in the Best Lawyers survey of the best law firms in the United States, has been recognized for patent litigation by LMG Life Sciences and Intellectual Asset Management, and was previously named among Patexia Insight’s Top Inter Partes Review Firms. The Legal 500 US has credited the Firm’s “superb trial lawyers with a long track record in dealing with complex patent litigation,” and noted that “when stakes are high in a patent case, Cravath is the team to engage.”
Cravath has extensive experience representing content owners, content distributors and others in prosecuting and defending copyright infringement claims, including in landmark actions that shape the law’s development. We have established important precedent impacting copyright-heavy industries, such as film, television, music and digital media, and recently won a U.S. Supreme Court decision holding that the Copyright Act permits damages recovery for any timely filed infringement claim, regardless of when the infringement occurred. A victory for all creators of copyrightable works, the ruling resolved a critical issue that had divided the federal appellate courts. In addition to our active litigation practice, we routinely advise clients on a variety of copyright issues, including those related to the Digital Millennium Copyright Act, renewal rights issues, digital media and other new and emerging technologies. We also regularly advise on potential copyright and other contractual issues in programming, recording and publishing contracts.
The breadth and depth of Cravath’s litigation expertise is invaluable in prosecuting (or defending) claims involving trade secrets. The Legal 500 US noted Cravath’s particular strength “in bringing complex, high‑value trade secret disputes to trial on behalf of plaintiffs in the insurance, finance and technology sectors, and defending them against claims,” as well as the Firm’s “considerable track record advising various parties on strategies to avoid trade secrets disputes.” Cravath also possesses substantial experience in investigating potential or suspected misuse or misappropriation of trade secrets. The Firm frequently advises clients on methods of protecting proprietary information, including confidentiality and noncompetition agreements with employees, and conducts due diligence with respect to unpatented proprietary information in connection with mergers and acquisitions and other transactions.
Cravath advises and represents clients on a wide range of issues arising under the trademark laws. We have defended clients against allegations of trademark infringement and trademark dilution, as well as against related claims of unfair competition and breach of trademark licensing agreements. We also have brought claims and counterclaims to enforce important trademark rights.
Named New York Law Journal’s “Litigation Department of the Year” three times in the past six years, most recently in 2024, and a Law360 “Firm of the Year” in 2024 and 2021, Cravath’s IP team has been ranked as a leading or top‑tier firm in the intellectual property space by Benchmark Litigation, Chambers USA, Chambers Global, IAM Patent 1000, LMG Life Sciences, The Legal 500 US and Best Lawyers Best Law Firms. In addition, we have earned repeated praise from clients and the market, including:
Deals & Cases
October 17, 2024
On October 15, 2024, the United States Court of Appeals for the Federal Circuit affirmed an inter partes review (“IPR”) decision by the Patent Trial and Appeal Board (“PTAB”) in favor of Cravath client ADT Inc., invalidating all claims of a patent at issue in litigation brought by Vivint, Inc.
Deals & Cases
May 11, 2024
On May 9, 2024, the U.S. Supreme Court ruled in favor of Cravath client Sherman Nealy, affirming the U.S. Court of Appeals for the Eleventh Circuit’s ruling that the Copyright Act entitles a copyright owner to obtain damages for any timely filed infringement claim, regardless of when the infringement occurred. The Supreme Court’s decision resolves a split between the Ninth and Eleventh Circuits and the Second Circuit and holds that Nealy may seek damages for copyright infringement claims against Warner Chappell Music.
Deals & Cases
January 29, 2024
On January 25, 2024, the U.S. District Court for the Southern District of New York entered judgments against appropriation artist Richard Prince and his co‑defendants Laurence Gagosian, Gagosian Gallery and Blum & Poe gallery.
Deals & Cases
October 09, 2023
On September 22, 2023, the U.S. District Court for the District of Massachusetts ruled in favor of Cravath clients Abiomed, Inc. and Abiomed Europe GmbH (together, “Abiomed”), denying a motion to dismiss litigation brought by Abiomed against German defendants Enmodes GmbH and its CEO Tim Kaufmann.
Deals & Cases
September 08, 2011
On September 6, 2011, the U.S. Judicial Panel on Multidistrict Litigation granted Cravath client Qualcomm Inc.’s request to centralize 11 lawsuits over PJC Logistics LLC’s vehicle tracking patent in Minnesota Federal Court. PJC alleged that certain mobile fleet management products manufactured by Qualcomm, and installed on hundreds of thousands of trucks and other vehicles, infringe U.S. Patent No. 5,223,844. In March 2011, PJC brought actions in nine district courts against hundreds of customers of fleet management products. In April 2011, Qualcomm filed a declaratory judgment action in the District of Minnesota alleging that the patent is invalid and not infringed by Qualcomm’s products. PJC subsequently filed additional infringement actions against Qualcomm and other suppliers of allegedly infringing fleet management systems in Texas. Qualcomm moved the Judicial Panel on Multidistrict Litigation to transfer all the actions to the District of Minnesota for coordinated pre-trial proceedings. After oral argument in July 2011, Qualcomm’s motion was granted.
Activities
May 08, 2025
On May 7, 2025, Cravath partner Sharonmoyee Goswami participated in the 7th annual Life Sciences Patent Network North America–Spring Conference, which was hosted by Life Sciences Intellectual Property Review from May 6‑7 in Boston. The conference hosted law firms, in‑house patent counsel and executives from pharmaceutical and biotech companies to discuss the latest legal rulings, legislative changes and strategic approaches transforming the life sciences IP landscape. Sharon spoke on a panel entitled “Patenting Women’s Health: The Rise of Femtech,” which reviewed topics about patenting products and services designed to support women’s health, including how to overcome eligibility hurdles for biomarkers and addressing divided infringement issues for diagnostics.
Activities
April 25, 2025
On April 24, 2025, Managing IP honored Cravath at the publication’s 2025 Americas Awards, which recognize “in‑house teams, firms, individuals and corporations behind the most innovative and challenging IP work of the past year, as well as those driving the international market.” The Firm was honored with an Impact Case of the Year award for its successful representation of client Sherman Nealy in an appeal before the U.S. Supreme Court, which ruled the Copyright Act entitles a copyright owner to obtain damages for any timely filed infringement claim, regardless of when the infringement occurred.
Activities
April 25, 2025
On April 25, 2025, Cravath partners Sasha Rosenthal‑Larrea and Sharonmoyee Goswami participated in Fordham Law School’s 32nd Annual Intellectual Property Law & Policy Conference, which took place from April 24‑25 in New York. The conference convened experts across the public and private sectors to discuss developments in the IP law and policy space. Sasha spoke on a panel entitled “Artificial Intelligence” during a session on copyright law, and Sharon spoke on a panel entitled “Patents & Remedies” during a session on patent law.
Activities
April 15, 2025
On April 3, 2025, Cravath partner Sharonmoyee Goswami led “Protect, Scale, Invest: The IP Playbook for Sustainability Leaders,” an event co‑hosted by Cravath in New York. Sharon was featured in a fireside chat for a discussion on strategically leveraging intellectual property to drive value and protect innovation in the energy transition market, including optimizing IP portfolios, scaling innovation in an evolving regulatory landscape, handling potential IP litigation, navigating IP risks and opportunities in transactions and understanding legal and economic trends.
Activities
March 31, 2025
On March 24, 2025, Cravath partner Sharonmoyee Goswami participated in the Banbury Center at Cold Spring Harbor Laboratory’s Government Challenges to U.S. Patent Rights meeting, which was held from March 23‑26 in Lloyd Harbor, New York. Sharon co‑chaired a session entitled “The Public & Private Sectors - Research Funding.”
Deals & Cases
October 17, 2024
On October 15, 2024, the United States Court of Appeals for the Federal Circuit affirmed an inter partes review (“IPR”) decision by the Patent Trial and Appeal Board (“PTAB”) in favor of Cravath client ADT Inc., invalidating all claims of a patent at issue in litigation brought by Vivint, Inc.
Deals & Cases
May 11, 2024
On May 9, 2024, the U.S. Supreme Court ruled in favor of Cravath client Sherman Nealy, affirming the U.S. Court of Appeals for the Eleventh Circuit’s ruling that the Copyright Act entitles a copyright owner to obtain damages for any timely filed infringement claim, regardless of when the infringement occurred. The Supreme Court’s decision resolves a split between the Ninth and Eleventh Circuits and the Second Circuit and holds that Nealy may seek damages for copyright infringement claims against Warner Chappell Music.
Deals & Cases
January 29, 2024
On January 25, 2024, the U.S. District Court for the Southern District of New York entered judgments against appropriation artist Richard Prince and his co‑defendants Laurence Gagosian, Gagosian Gallery and Blum & Poe gallery.
Deals & Cases
October 09, 2023
On September 22, 2023, the U.S. District Court for the District of Massachusetts ruled in favor of Cravath clients Abiomed, Inc. and Abiomed Europe GmbH (together, “Abiomed”), denying a motion to dismiss litigation brought by Abiomed against German defendants Enmodes GmbH and its CEO Tim Kaufmann.
Deals & Cases
September 08, 2011
On September 6, 2011, the U.S. Judicial Panel on Multidistrict Litigation granted Cravath client Qualcomm Inc.’s request to centralize 11 lawsuits over PJC Logistics LLC’s vehicle tracking patent in Minnesota Federal Court. PJC alleged that certain mobile fleet management products manufactured by Qualcomm, and installed on hundreds of thousands of trucks and other vehicles, infringe U.S. Patent No. 5,223,844. In March 2011, PJC brought actions in nine district courts against hundreds of customers of fleet management products. In April 2011, Qualcomm filed a declaratory judgment action in the District of Minnesota alleging that the patent is invalid and not infringed by Qualcomm’s products. PJC subsequently filed additional infringement actions against Qualcomm and other suppliers of allegedly infringing fleet management systems in Texas. Qualcomm moved the Judicial Panel on Multidistrict Litigation to transfer all the actions to the District of Minnesota for coordinated pre-trial proceedings. After oral argument in July 2011, Qualcomm’s motion was granted.
Activities
May 08, 2025
On May 7, 2025, Cravath partner Sharonmoyee Goswami participated in the 7th annual Life Sciences Patent Network North America–Spring Conference, which was hosted by Life Sciences Intellectual Property Review from May 6‑7 in Boston. The conference hosted law firms, in‑house patent counsel and executives from pharmaceutical and biotech companies to discuss the latest legal rulings, legislative changes and strategic approaches transforming the life sciences IP landscape. Sharon spoke on a panel entitled “Patenting Women’s Health: The Rise of Femtech,” which reviewed topics about patenting products and services designed to support women’s health, including how to overcome eligibility hurdles for biomarkers and addressing divided infringement issues for diagnostics.
Activities
April 25, 2025
On April 24, 2025, Managing IP honored Cravath at the publication’s 2025 Americas Awards, which recognize “in‑house teams, firms, individuals and corporations behind the most innovative and challenging IP work of the past year, as well as those driving the international market.” The Firm was honored with an Impact Case of the Year award for its successful representation of client Sherman Nealy in an appeal before the U.S. Supreme Court, which ruled the Copyright Act entitles a copyright owner to obtain damages for any timely filed infringement claim, regardless of when the infringement occurred.
Activities
April 25, 2025
On April 25, 2025, Cravath partners Sasha Rosenthal‑Larrea and Sharonmoyee Goswami participated in Fordham Law School’s 32nd Annual Intellectual Property Law & Policy Conference, which took place from April 24‑25 in New York. The conference convened experts across the public and private sectors to discuss developments in the IP law and policy space. Sasha spoke on a panel entitled “Artificial Intelligence” during a session on copyright law, and Sharon spoke on a panel entitled “Patents & Remedies” during a session on patent law.
Activities
April 15, 2025
On April 3, 2025, Cravath partner Sharonmoyee Goswami led “Protect, Scale, Invest: The IP Playbook for Sustainability Leaders,” an event co‑hosted by Cravath in New York. Sharon was featured in a fireside chat for a discussion on strategically leveraging intellectual property to drive value and protect innovation in the energy transition market, including optimizing IP portfolios, scaling innovation in an evolving regulatory landscape, handling potential IP litigation, navigating IP risks and opportunities in transactions and understanding legal and economic trends.
Activities
March 31, 2025
On March 24, 2025, Cravath partner Sharonmoyee Goswami participated in the Banbury Center at Cold Spring Harbor Laboratory’s Government Challenges to U.S. Patent Rights meeting, which was held from March 23‑26 in Lloyd Harbor, New York. Sharon co‑chaired a session entitled “The Public & Private Sectors - Research Funding.”
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.